Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Feigen

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Annals of Ophthalmology|January 1, 1990
External ocular inflammatory effects of lipoxygenase enzyme productsS A Napoli, C Helm, M S Insler, et al.
Cardiovascular Research|March 1, 1993
Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid arteryW E Rote, S W Werns, J H Davis, et al.
Circulation Research|April 1, 1977
Influence of inhibitors of prostaglandin synthesis on renal vascular resistance and on renal vascular responses to vasopressor and vasodilator agents in the catB M Chapnick, P W Paustian, L P Feigen, et al.
Circulation|January 1, 1996
The protective dose of the potent GPIIb/IIIa antagonist SC-54701A is reduced when used in combination with aspirin and heparin in a canine model of coronary artery thrombosisL G Frederick, O D Suleymanov, L W King, et al.
European Journal of Clinical Investigation|July 1, 1997
Thrombosis triggered by severe arterial lesions is inhibited by oral administration of a glycoprotein IIb/IIIa antagonistJ J Badimon, B Meyer, L P Feigen, et al.
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|September 1, 1978
Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2P J Kadowitz, B M Chapnick, L P Feigen, et al.
The Journal of Biological Chemistry|January 26, 1996
The amino-terminal one-third of alpha IIb defines the ligand recognition specificity of integrin alpha IIb beta 3J C Loftus, C E Halloran, M H Ginsberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1993
SC-49992, a mimetic of the peptide arginine-glycine-aspartic acid-phenylalanine that blocks platelet aggregation, enhances recombinant tissue plasminogen activator-induced thrombolysis and prevents reocclusion in a canine model of coronary artery thrombosisL P Feigen, N S Nicholson, L W King, et al.
International Journal of Peptide and Protein Research|August 1, 1991
Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma and inhibit platelet aggregationK F Fok, S G Panzer-Knodle, N S Nicholson, et al.
Circulation|January 15, 1995
Extended inhibition of platelet aggregation with the orally active platelet inhibitor SC-54684AJ A Szalony, N F Haas, A K Salyers, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Annals of Ophthalmology|January 1, 1990
External ocular inflammatory effects of lipoxygenase enzyme productsS A Napoli, C Helm, M S Insler, et al.
Cardiovascular Research|March 1, 1993
Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid arteryW E Rote, S W Werns, J H Davis, et al.
Circulation Research|April 1, 1977
Influence of inhibitors of prostaglandin synthesis on renal vascular resistance and on renal vascular responses to vasopressor and vasodilator agents in the catB M Chapnick, P W Paustian, L P Feigen, et al.
Circulation|January 1, 1996
The protective dose of the potent GPIIb/IIIa antagonist SC-54701A is reduced when used in combination with aspirin and heparin in a canine model of coronary artery thrombosisL G Frederick, O D Suleymanov, L W King, et al.
European Journal of Clinical Investigation|July 1, 1997
Thrombosis triggered by severe arterial lesions is inhibited by oral administration of a glycoprotein IIb/IIIa antagonistJ J Badimon, B Meyer, L P Feigen, et al.
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|September 1, 1978
Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2P J Kadowitz, B M Chapnick, L P Feigen, et al.
The Journal of Biological Chemistry|January 26, 1996
The amino-terminal one-third of alpha IIb defines the ligand recognition specificity of integrin alpha IIb beta 3J C Loftus, C E Halloran, M H Ginsberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1993
SC-49992, a mimetic of the peptide arginine-glycine-aspartic acid-phenylalanine that blocks platelet aggregation, enhances recombinant tissue plasminogen activator-induced thrombolysis and prevents reocclusion in a canine model of coronary artery thrombosisL P Feigen, N S Nicholson, L W King, et al.
International Journal of Peptide and Protein Research|August 1, 1991
Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma and inhibit platelet aggregationK F Fok, S G Panzer-Knodle, N S Nicholson, et al.
Circulation|January 15, 1995
Extended inhibition of platelet aggregation with the orally active platelet inhibitor SC-54684AJ A Szalony, N F Haas, A K Salyers, et al.
Pageof 5